Pfizer Raises Revenue Outlook Amid Pressure to Prove Post-COVID Value
Pfizer has raised its revenue and earnings outlook for the year, now expecting between $61 billion and $64 billion in revenue and adjusted earnings per share of $2.75 to $2.95. This optimistic
